PD-L1 Status and Survival in Patients With Lung Cancer-Reply
JAMA
.
2019 Aug 27;322(8):783-784.
doi: 10.1001/jama.2019.9196.
Authors
Peter Grant Miller
1
,
Gerald Li
2
,
Gaurav Singal
2
Affiliations
1
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.
2
Foundation Medicine Inc, Cambridge, Massachusetts.
PMID:
31454037
DOI:
10.1001/jama.2019.9196
No abstract available
Publication types
Letter
Comment
MeSH terms
Adenocarcinoma*
B7-H1 Antigen
Carcinoma, Non-Small-Cell Lung*
Genomics
Humans
Lung Neoplasms*
Substances
B7-H1 Antigen